Model Parameter Estimation and Uncertainty: a Report of the Ispor-smdm Modeling Good Research Practices Task Force-6 Background to the Task Forcemodel-parameter-estimation-and- Uncertainty-analysis.asp). a Summary of These Articles Was Pre- Sented at a Plenary Session at the Ispor 16th Annual Intern
暂无分享,去创建一个
Jonathan Karnon | Mark J Sculpher | Milton C Weinstein | Andrew H Briggs | Elisabeth A L Fenwick | A David Paltiel | M. Weinstein | M. Sculpher | J. Karnon | A. Briggs | E. Fenwick | A. Paltiel | A. Briggs | Elisabeth A. L. Fenwick | Milton C. Weinstein | Dphil | Andrew H. Briggs
[2] A E Ades,et al. Expected Value of Sample Information Calculations in Medical Decision Modeling , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.
[3] W. Edmunds,et al. Impact of Model, Methodological, and Parameter Uncertainty in the Economic Analysis of Vaccination Programs , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[4] M. Sculpher,et al. Decision Modelling for Health Economic Evaluation , 2006 .
[5] Karl Claxton,et al. A Framework for Addressing Structural Uncertainty in Decision Models , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[6] Andrew Thomas,et al. The BUGS project: Evolution, critique and future directions , 2009, Statistics in medicine.
[7] Milton C. Weinstein,et al. Incorporating Calibrated Model Parameters into Sensitivity Analyses , 2012, PharmacoEconomics.
[8] A A Stinnett,et al. The negative side of cost-effectiveness analysis. , 1997, JAMA.
[9] M. Mcgrath. Cost Effectiveness in Health and Medicine. , 1998 .
[10] Mirjam Kretzschmar,et al. Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5 , 2012, Value in Health.
[11] Simon G Thompson,et al. Accounting for uncertainty in health economic decision models by using model averaging , 2009, Journal of the Royal Statistical Society. Series A,.
[12] J. Caro,et al. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[13] V Demicheli,et al. Are guidelines for peer-reviewing economic evaluations necessary? A survey of current editorial practice. , 1995, Health economics.
[14] Uwe Siebert,et al. Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[15] Jonathan Karnon,et al. A Hybrid Cohort Individual Sampling Natural History Model of Age-Related Macular Degeneration: Assessing the Cost-Effectiveness of Screening Using Probabilistic Calibration , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.
[16] Richard G. White,et al. Calibrating Models in Economic Evaluation , 2012, PharmacoEconomics.
[17] Bas Groot Koerkamp,et al. Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods. , 2006, Health economics.
[18] D. Goodin. The cambridge dictionary of statistics , 1999 .
[19] A Briggs,et al. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. , 1994, Health economics.
[20] Jonathan Karnon,et al. Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[21] Karl Claxton,et al. Exploring Uncertainty in Cost-Effectiveness Analysis , 2012, PharmacoEconomics.
[22] M. Drummond,et al. A rational framework for decision making by the National Institute For Clinical Excellence (NICE) , 2002, The Lancet.
[23] Murray Krahn,et al. Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[24] Jeremy E. Oakley,et al. Uncertain Judgements: Eliciting Experts' Probabilities , 2006 .
[25] Karl Claxton,et al. Characterizing structural uncertainty in decision analytic models: a review and application of methods. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[26] T. Lumley. Network meta‐analysis for indirect treatment comparisons , 2002, Statistics in medicine.
[27] A E Ades,et al. Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.
[28] A Briggs,et al. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. , 1998, Health economics.
[29] Anthony O'Hagan,et al. Calculating Partial Expected Value of Perfect Information via Monte Carlo Sampling Algorithms , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.
[30] Karen M Kuntz,et al. Multiparameter calibration of a natural history model of cervical cancer. , 2007, American journal of epidemiology.
[31] D. Owens,et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.